课题基金 / 基金详情

Construction of focused library and the development of protein tyrosine phosphatase inhibitor

Construction of focused library and the development of protein tyrosine phosphatase inhibitor
重点文库构建及蛋白酪氨酸磷酸酶抑制剂的开发
批准号:
15310144
负责人:
SODEOKA Mikiko
金额:
$10.05万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004

项目摘要

项目成果

SODEOKA Mikiko的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Aiming at developing PTP (protein tyrosine phosphatase), a "focused-library" (compounds having a "core" structure that can interact with the conserved catalytic site of PTP as a phosphate mimic and having "various" substituents that may interact with the unique region of each enzyme) was synthesized. Construction of a new library having L-ascorbic acid as a "core" structure was examined. We have already developed an efficient method for carbamate synthesis using a polymer-supported N-hydroxysuccinimide (NHS). Using this method an ascorbic acid-carbamate library was synthesized. The carbamate derivatives were prepared either from 6-amino-ascorbic acid and various alcohols, or from 5-dehydroxy-ascorbic acid and various amines. The inhibitory activity of these compounds (about 80 compounds) toward PTP1B (PTP) was tested, and several compounds showed the moderate inhibitory activity.The 4-O-alkyated tetronic acid derivatives as second generation library was synthesized, and 4-benzyl-RK-682 has been found to possess a selective inhibitory activity for heparanase. 4-Benzyl-RK-682 also inhibited the invasion and migration of human fibrosarcoma HT 1060 cells.The isobenzofuranone library was also synthesized, and among them we have found the strong PKCα activators.
期刊论文(28)
专著(0)
科研奖励(0)
会议论文
Y.Baba, S.Mayumi, G.Hirai, H.Kawasaki, Y.Ogoshi, T.Yanagisawa, Y.Hashimoto, M.Sodeoka: "Evaluation of Series of Isobenzofuranone Dimers as PKCa Ligands : Implication for the Distance between the Two Ligand Binding Sites"Bioorg.Med.Chem.Lett.. Vol.14(In Pr
Y.Baba、S.Mayumi、G.Hirai、H.Kawasaki、Y.Ogoshi、T.Yanagisawa、Y.Hashimoto、M.Sodeoka:“一系列异苯并呋喃酮二聚体作为 PKCa 配体的评估:对两者之间距离的影响
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: 10.1016/j.tetlet.2005.01.018
发表时间: 2005-02
期刊: Tetrahedron Letters
影响因子: 1.8
作者: [Y. Hamashima;Toshiaki Suzuki;Yuta Shimura;Tadashi Shimizu;N. Umebayashi;Toshihiro Tamura;Naoki Sasamoto;M. Sodeoka]
通讯作者: Y. Hamashima;Toshiaki Suzuki;Yuta Shimura;Tadashi Shimizu;N. Umebayashi;Toshihiro Tamura;Naoki Sasamoto;M. Sodeoka
DOI: 10.1016/j.bmcl.2004.02.097
发表时间: 2004-06-07
期刊: BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
影响因子: 2.7
作者: [Baba, Y, Ogoshi, Y, Sodeoka, M]
通讯作者: Sodeoka, M
Y.Baba, Y.Ogoshi, G.Hirai, T.Yanagisawa, K.Nagamatsu, S.Mayumi, Y.Hashimoto, M.Sodeoka: "Design, Synthesis, and Structure-Activity Relationship of New Isobenzofuranone Ligands of Protein Kinase C."Bioorg.Med.Chem.Lett.. Vol.14(In Press). (2004)
Y.Baba、Y.Ogoshi、G.Hirai、T.Yanagisawa、K.Nagamatsu、S.Mayumi、Y.Hashimoto、M.Sodeoka:“蛋白激酶 C 新型异苯并呋喃酮配体的设计、合成和构效关系
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
10
    Clarification research for molecular mechanism of a novel type of protein kinase C inhibitor
    海外基金